Clinical Innovations, Inc.

Bellflower, California 90706

2 studies enrolling now · 11 studies all time

What they study most

Bipolar Depression, Bipolar Disorder, Bipolar I Disorder, Bipolar II Disorder, Depressive Disorder, Major, Major Depressive Disorder, Post Traumatic Stress Disorder, Schizophrenia, Schizophrenia; Psychosis, Treatment Resistant Depression

Studies at this site

• A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3) — Recruiting now
• A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression) — Recruiting now
• A Study to Test Different Doses of BI 1569912 in People With Depression — Completed
• Study Evaluating Safety and Efficacy of Ropanicant in MDD Patients — Completed
• A Study to Test Long-term Safety of Iclepertin in People With Schizophrenia Who Took Part in a Previous CONNEX Study — Stopped early
• Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD — Running, not enrolling
• Clinical Trial of Iclepertin Effect on Cognition and Functional Capacity in Schizophrenia (CONNEX-2) — Completed
• A Clinical Study That Will Evaluate How Well SEP-363856 Works and How Safe it is in People With Schizophrenia That Switch to SEP-363856 From Their Current Antipsychotic Medication — Completed
• An Open-label Study to Assess the Long-term Safety, Tolerability, and Efficacy of KarXT in Adult Patients With Schizophrenia (EMERGENT-5) — Completed
• A Study of JZP150 in Adults With Posttraumatic Stress Disorder — Completed
• A Study to Assess Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Adult Patients With Schizophrenia (EMERGENT-3) — Completed